6533b82ffe1ef96bd12950f0

RESEARCH PRODUCT

Inhalation therapy in the next decade

Sara MaioEmiel F.m. WoutersDina ViscaNicola ScichiloneSilvana CianchettiMassimo PistolesiRoberto TorchioSandro AmaducciRiccardo MessinaPatrizia PignattiAnnalisa Di MariaClaudio F. DonnerAntonio SpanevelloGiuseppe Di MariaGiorgio ColomboGianfranco Maria BeghiGiovanni ViegiFederico LavoriniAlessandro CeliMario CazzolaMarzia SimoniPierluigi PaggiaroDaniela CastigliaClaudia ManniniShaylynn Yu Hui XinSandra BaldacciAlida BenfanteDavid PriceElena BacciMaria Laura BartoliClaudia CrimiManuela LatorreSara BrighindiShwana TanFederico L. DenteMartina Stagno D'alcontresLucio Casali

subject

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyRespiratory TherapyEuropean Seminars in Respiratory MedicineCost-Benefit Analysiseducationlcsh:MedicineMedication adherenceSettore MED/10 - Malattie Dell'Apparato RespiratorioCOPD; European Seminars in Respiratory Medicine; Inhalation therapyINSPIRATORY FLOW-RATEHistory 21st CenturyOBSTRUCTIVE PULMONARY-DISEASEPulmonary Disease Chronic ObstructivePATIENT ADHERENCECOPD; European Seminars in Respiratory Medicine; Inhalation therapy; Pulmonary and Respiratory MedicineITALIAN GENERAL-PRACTITIONERSmedicinePulmonary MedicineHumansCOPDMortalityMEDICATION ADHERENCEIntensive care medicineAsthmaHEALTH-CARE PROFESSIONALSCOPDInhalationbusiness.industryDRY POWDER INHALERlcsh:ROBJECTIVELY IDENTIFIED COMORBIDITIESIMPROVES LUNG-FUNCTIONHistory 20th Centurymedicine.diseaseDry-powder inhalerAsthmarespiratory tract diseasesRespiratory MedicineREAL-LIFEItalyInhalation therapyFemaleCardiology and Cardiovascular Medicinebusiness

description

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

10.4081/monaldi.2018.886https://doi.org/10.4081/monaldi.2018.886